• Pharma
  • October 24, 2018
  • 155 views
Sun Pharma launches psoriasis treatment drug Ilumya in US

Sun Pharmaceutical Industries Tuesday said it has launched its plaque psoriasis treatment drug Ilumya (tildrakizumab-asmn) in the US market.Ilumya in the strength of 100 mg/mL is now available in the…

  • Pharma
  • October 24, 2018
  • 133 views
Johnson and Johnson asked to cut down price of new TB drug

Medicines Sans Frontiers (MSF) has called upon US drug maker c (J&J) to cut down the price of its new tuberculosis drug Bedaquiline, as the high price of the drug…

  • Pharma
  • October 23, 2018
  • 143 views
Mumbai: PIL against antibiotics’ sale without prescription

MUMBAI: A lawyer has filed a PIL in the Bombay HC against the Union and state governments, Central Drugs Standard Control Organization (CDSCO) and drug regulator to prevent the rampant…

  • Pharma
  • October 22, 2018
  • 139 views
Pharma co buys Rs 350-cr plot

One of the biggest pharmaceutical companies in the country is moving its corporate headquarters. And, in doing so, it has given a fillip to the city’s realty market by buying…

  • Pharma
  • October 22, 2018
  • 129 views
Merck KGaA says might strike partnership deal this year

MUNICH: German drugmaker Merck KGaA might agree partnership deals to jointly develop two of its most promising experimental medicines with a rival as early as this year, but more likely…

  • Pharma
  • October 20, 2018
  • 169 views
AbbVie CFO Chase stepping down, to retire by mid-year 2019

AbbVie Inc said on Friday that Chief Financial Officer William Chase is retiring in mid-2019 and named its controller, Robert Michael, his immediate successor as CFO. Michael, 48, will report…

  • Pharma
  • October 20, 2018
  • 227 views
Pharmacist who wouldn’t fill miscarriage drug is out

PETOSKEY, Mich.: A Michigan pharmacist accused of refusing to fill a prescription to help a woman complete a miscarriage no longer works for the Meijer retail chain. Meijer spokeswoman Christina…

  • Pharma
  • October 20, 2018
  • 186 views
Sanofi drug Dupixent wins U.S. FDA approval to treat asthma

France’s Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in patients with two types of asthma.…

  • Pharma
  • October 19, 2018
  • 226 views
FDA snubs Novartis bid to repurpose inflammation drug for heart attacks

By John Miller ZURICH: The U.S. Food and Drug Administration has rejected Novartis’s bid to repurpose a drug now approved for rare inflammatory diseases to be used in a group…

  • Pharma
  • October 18, 2018
  • 237 views
Uttar Pradesh government planned to open Six Pharma Parks

Six Pharma Parks has been planned to set-up in the Uttar Pradesh state as the state has been received an investment commitment of about Rs 5,000-6,000 crore from domestic and…